Magnetic resonance imaging–targeted vs. conventional transrectal ultrasound–guided prostate biopsy: Single-institution, matched cohort comparison Read More
Magnetic Resonance Imaging-Defined Prostate-Specific Antigen Density Significantly Improves the Risk Prediction for Clinically Significant Prostate Cancer on Biopsy Read More
Cognitive Versus Software Fusion for MRI-targeted Biopsy: Experience Before and After Implementation of Fusion Read More
Magnetic Resonance Imaging Provides Added Value to the Prostate Cancer Prevention Trial Risk Calculator for Patients With Estimated Risk of High-grade Prostate Cancer Less Than or Equal to 10% Read More
